Innate Pharma (IPHYF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,110 | -3,840 | -4,110 | -9,720 | N/A |
| Depreciation Amortization | 3,110 | 1,160 | 1,070 | 1,250 | N/A |
| Other Working Capital | -1,720 | -12,500 | -11,000 | 26,630 | N/A |
| Other Operating Activity | 620 | 620 | 570 | -80 | 0 |
| Operating Cash Flow | $-24,100 | $-14,560 | $-13,470 | $18,080 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,390 | -420 | -1,570 | -440 | N/A |
| Net Acquisitions | 0 | -150 | 0 | 0 | N/A |
| Other Investing Activity | -2,690 | -700 | -2,810 | 3,840 | 0 |
| Investing Cash Flow | $-5,080 | $-1,270 | $-4,380 | $3,400 | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 63,730 | 26,130 | -2,760 | -910 | 0 |
| Financing Cash Flow | $63,730 | $26,130 | $-2,760 | $-910 | $N/A |
| Exchange Rate Effect | -90 | 30 | 10 | 20 | N/A |
| Beginning Cash Position | 50,990 | 40,620 | 59,930 | 44,310 | N/A |
| End Cash Position | 85,450 | 50,950 | 39,330 | 64,910 | N/A |
| Net Cash Flow | $34,460 | $10,320 | $-20,600 | $20,590 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,100 | -14,560 | -13,470 | 18,080 | N/A |
| Free Cash Flow | -24,100 | -14,560 | -13,470 | 18,080 | 0 |